Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Canton Strategic HoldingsCNTN +0.75%32 Cash Ratio is 14.18 as of Jun. 2026, which is 297% above its 10-year median of 3.57. GuruFocus rates CNTN with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 1,377 Biotechnology companies, Canton Strategic Holdings ranks better than 97.89% on this metric.
Canton Strategic Holdings has a Cash Ratio of 14.18. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Canton Strategic Holdings's Cash Ratio or its related term are showing as below:
CNTN'
s Cash Ratio Range Over the Past 10 Years
Min: 0.01 Med: 3.57 Max: 36.4
Current: 14.18
During the past 7 years, Canton Strategic Holdings's highest Cash Ratio was 36.40. The lowest was 0.01. And the median was 3.57.
CNTN's Cash Ratio is ranked better than 97.89% of 1377
companies
in the Biotechnology industry
Industry Median: 2.96
vs CNTN: 14.18
Canton Strategic Holdings (NAS:CNTN) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Canton Strategic Holdings Cash Ratio Related Terms
Canton Strategic Holdings Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Canton Strategic Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canton Strategic Holdings Cash Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Canton Strategic Holdings's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Canton Strategic Holdings's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Canton Strategic Holdings (CNTN) has a Cash Ratio of 14.18 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Canton Strategic Holdings and its competitors. This is 297% above median its historical median of 3.57. Over the past decade, Canton Strategic Holdings' Cash Ratio has ranged from 0.01 to 36.40. According to the industry distribution chart, Canton Strategic Holdings ranks #29 out of 1377 companies in the Biotechnology industry, placing it in the top 2.1%.
Is Canton Strategic Holdings' Cash Ratio too high?
Canton Strategic Holdings' current Cash Ratio of 14.18 is 297% above median its 10-year median of 3.57. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 36.40. The Biotechnology industry median Cash Ratio is 2.96. Canton Strategic Holdings' value of 14.18 is 379.1% above this industry median. Based on the distribution chart, Canton Strategic Holdings ranks #29 out of 1377 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Canton Strategic Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Canton Strategic Holdings' Cash Ratio compare to UNCY and ABOS?
According to the Biotechnology industry distribution chart, Canton Strategic Holdings ranks #29 out of 1377 companies for Cash Ratio. This places Canton Strategic Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 2.96. Canton Strategic Holdings' value of 14.18 is 379.1% above this benchmark. Historically, Canton Strategic Holdings' own Cash Ratio has ranged from 0.01 to 36.40 over the past decade. While the company's 10-year median is 3.57 vs. the industry median of 2.96, Canton Strategic Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Biotechnology company?
The median Cash Ratio among Biotechnology companies is 2.96, based on 1,377 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Canton Strategic Holdings's current Cash Ratio of 14.18 is 379.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Canton Strategic Holdings and its competitors. For the Biotechnology industry, the median Cash Ratio is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Canton Strategic Holdings's current Cash Ratio is 14.18, which is 297% above median its own 10-year median of 3.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canton Strategic Holdings stock overvalued right now?
Canton Strategic Holdings (CNTN) has a current Cash Ratio of 14.18. The current Cash Ratio is 14.18, which is 297% above median its 10-year median of 3.57 and 379.1% above the Biotechnology industry median of 2.96. Canton Strategic Holdings' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Canton Strategic Holdings (CNTN), the current Cash Ratio is 14.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
32GF Score
Get the complete analysis for CNTN
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CNTN has been successfully added to your 
